Alfa Chemistry Launches API Research & Development Platform for the Pharmaceutical Industry
The past decade has witnessed a surge in the demand for active pharmaceutical ingredients (APIs). Alfa Chemistry responds quickly to such a fact and launches an integrated platform with small molecule APIs/intermediates development and manufacturing capabilities from preclinical to commercial stages. Together with the previously launched 9 popular APIs that are readily-available, including dexmedetomidine hydrochloride, donepezil, lenalidomide, parecoxib sodium, rivaroxaban, tofacitinib citrate, tamoxifen citrate , epalrestat and edaravone , Alfa Chemistry is now well-positioned to help move forward customers’ projects in a faster pace for drug developers worldwide. “As a research-driven and customer-based company, we’re committed to help our clients shorten their time for drug development and lower the cost of drug manufacturing. We enable customers to benefit from our tailored methods that balance their needs in terms of speed and cost,” says the Marketing Chief of Alfa Chemistr...